Join
Live feed
·
PRReleasevia Quantisnow
Delcath Systems Inc. logo

Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026

ByQuantisnow·Wall Street's wire, on your screen.
DCTH· Delcath Systems Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DCTH (Delcath Systems Inc.) and more on Quantisnow.